Quasar passes FDA inspection with no 483 findingsquasar
Quasar passes FDA inspection with no 483 findings
An FDA inspection was conducted at the Quasar manufacturing facility in Shenzhen, October 31 to November 3, 2016.
This is the second consecutive FDA inspection Quasar passed with ZERO findings (no 483). This result endorses Quasar’s commitment to being a world-class medical device manufacturer.
Consistent with Quasar’s legacy of maintaining high quality standards, we focus on quality throughout the facility, whether in employee training, process development, equipment validations and all phases to manufacturing.